Prevention of ovarian damage induced by cyclophosphamide in adult female mice by hormonal manipulations

Vinícius Milani Budel, Róbert Kiss, Yvan de Launoit, André Danguy, Ghanem Atassi, J L Pasteels, Robert Paridaens
In: Reproduction · 1988 · vol. 84(2) , pp. 625–633 · doi:10.1530/jrf.0.0840625 · PMID:3199382 · W1991028125
article OA: bronze CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-07, 2026-07-18 ⓘ

Cyclophosphamide treatment in mice significantly reduced developing ovarian follicles and increased degenerating ones, but danazol administration effectively prevented this damage by inhibiting LH/FSH secretion.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Doses of 10 or 20 mg cyclophosphamide/kg body weight were administered daily to mice for up to 20 days. This caused significant reductions in the incidence of prenatal (developing) follicles and significant increases in atretic (degenerating) follicles within the ovaries. Attempts to prevent cyclophosphamide-induced damage by simultaneous treatment with oestrogen alone, oestrogen plus progesterone, or danazol (a synthetic androgen) demonstrated that danazol effectively prevented the ovarian damage. The efficacy of danazol was considered to be due to its ability to inhibit LH/FSH secretion and, indirectly, the development of new ovarian follicles.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (16)

Source provenance

openalex
last seen: 2026-05-14T06:03:08.038466+00:00
License: CC0 · commercial use OK